Detalles de la búsqueda
1.
Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials.
Support Care Cancer;
30(11): 8655-8666, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35655045
2.
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.
Breast Cancer Res Treat;
188(3): 631-640, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34148205
3.
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
Int J Clin Oncol;
26(5): 841-850, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33783657
4.
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial.
Lancet Oncol;
20(8): 1148-1159, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31296491
5.
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study.
Br J Cancer;
120(2): 172-182, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30568294
6.
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial.
Lancet Oncol;
18(7): 917-928, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28592386
7.
Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study.
BioDrugs;
36(1): 55-69, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133617
8.
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma.
Int J Radiat Oncol Biol Phys;
114(3): 422-432, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35850363
9.
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
Breast Cancer Res Treat;
122(2): 409-18, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20454927
10.
[A study of phonon vibration like modes for aggregation structure in silicate melts by high temperature Raman spectrum].
Guang Pu Xue Yu Guang Pu Fen Xi;
30(5): 1261-5, 2010 May.
Artículo
en Zh
| MEDLINE | ID: mdl-20672614
11.
A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.
J Clin Oncol;
34(11): 1197-207, 2016 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26858335
12.
Sunitinib in metastatic renal cell carcinoma: an ethnic Asian subpopulation analysis for safety and efficacy.
Asia Pac J Clin Oncol;
10(3): 237-45, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24576311
13.
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.
J Geriatr Oncol;
4(4): 346-52, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24472478
14.
Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials.
Clin Breast Cancer;
12(4): 240-6, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22658378
15.
Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer.
Eur J Cancer;
45(17): 2940-6, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19683429
16.
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
J Clin Oncol;
25(33): 5210-7, 2007 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17968020
Resultados
1 -
16
de 16
1
Próxima >
>>